Skip to main content

Grade 2 Hand-foot Syndrom

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Quanta Therapeutics
Quanta TherapeuticsCA - South SF
1 program
1
Onco-Repair/ PlaceboPhase 31 trial
Active Trials
NCT03612011Completed72Est. Jun 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Quanta TherapeuticsOnco-Repair/ Placebo

Clinical Trials (1)

Total enrollment: 72 patients across 1 trials

NCT03612011Quanta TherapeuticsOnco-Repair/ Placebo

Efficacy of the Cosmetic Product "Onco-Repair" on Grade 2 Hand Foot Syndrome

Start: Jul 2018Est. completion: Jun 201972 patients
Phase 3Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.